Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Tzield | teplizumab-mzwv | Provention Bio | N-761183 RX | 2022-11-17 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
tzield | Biologic Licensing Application | 2023-12-08 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
type 1 diabetes mellitus | EFO_0001359 | D003922 | E10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | 1 | — | — | 1 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | 1 | — | — | 1 |
Drug common name | Teplizumab |
INN | teplizumab |
Description | Teplizumab (humanized mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1743078 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB06606 |
UNII ID | S4M959U2IJ (ChemIDplus, GSRS) |